Digital game to improve metabolic control and quality of life in children with Type 1 diabetes
The Effect Of Model-Based Dıgıtal Game On Metabolıc Control, Self-Effıcıency And Qualıty Of Lıfe In Chıldren Wıth Type 1 Dıabetes
This study is testing whether a digital game can help children with Type 1 diabetes manage their condition better and improve their quality of life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 58 (estimated) |
| Ages | 8 Years to 13 Years |
| Sex | All |
| Sponsor | Abant Izzet Baysal University Academic / other |
| Locations | 2 sites (Bolu and 1 other locations) |
| Trial ID | NCT05923632 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the impact of a model-based digital game on metabolic control, self-efficacy, and quality of life in children aged 8-13 diagnosed with Type 1 diabetes mellitus (T1DM). It is designed as a randomized controlled trial with a pre-post test parallel group approach. Participants will be recruited from pediatric endocrinology outpatient clinics and will be randomly assigned to either an experimental group receiving the digital game intervention or a control group receiving standard diabetes education. The study will assess various outcomes related to diabetes management and overall well-being.
Who should consider this trial
Good fit: Ideal candidates for this study are children aged 8-13 who have been diagnosed with Type 1 diabetes for at least six months and can communicate verbally.
Not a fit: Patients with other chronic diseases in addition to Type 1 diabetes may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could enhance metabolic control and improve the quality of life for children with Type 1 diabetes.
How similar studies have performed: While the use of digital games in diabetes management is emerging, this specific approach is relatively novel and has not been extensively tested in similar studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Being in the 8-13 age range, * Being diagnosed with T1DM at least 6 months ago, * Ability to read and write Turkish, * Ability to communicate verbally, * To have Internet access, * Computer, tablet, etc. to have and use technological tools, * To volunteer to participate in the study Exclusion Criteria: • Having another chronic disease other than T1DM
Where this trial is running
Bolu and 1 other locations
- Bolu Abant İzzet Baysal Üniversitesi — Bolu, Turkey (Türkiye) (Recruiting)
- Zonguldak Bülent Ecevit Üniversitesi — Zonguldak, Turkey (Türkiye) (Recruiting)
Study contacts
- Principal investigator: Özgür Bahadır, Lecturer — Zonguldak Bulent Ecevit University
- Study coordinator: Bedriye AK, Associate Prof.Dr.
- Email: bedriye_ak@yahoo.com
- Phone: +905327633151
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.